Imiglucerase is an intravenous enzyme replacement therapy for Gaucher disease.1 The mechanism of action of imiglucerase is presented in Figure 1. For further information on imiglucerase, please consult your local prescribing information.
Mechanism of action of imiglucerase1,2
C-ANPROM/INT//7568; Date of preparation: September 2020
- Sanofi Genzyme. Cerezyme® EU Summary of Product Characteristics. Last updated March 2020.
- Stirnemann J, Belmatoug N, Camou F, et al. A review of Gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci 2017; 18: 441.